Primary Biliary Cholangitis, PBC
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Case group: Collected patients with PBC admitted to Beijing Ditan Hospital from 2008 to 2023 as the case group. Inclusion criteria: (1). Primary biliary cholangitis or cirrhosis;(2). Age >= 18 years. 2. Control group: Collected patients with chronic hepatitis B-related cirrhosis admitted to Beijing Ditan Hospital from 2008 to 2023 as the control group. Inclusion criteria: (1). Chronic hepatitis B-related cirrhosis; (2). Age >= 18 years.
Exclusion criteria
Exclusion criteria: 1.Exclusion criteria for the case group: (1).Exclusion of viral hepatitis and cirrhosis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis and cirrhosis, drug-induced liver injury, Wilson’s disease, primary sclerosing cholangitis, hepatic sinusoidal obstruction syndrome, Budd-Chiari syndrome, or other liver diseases; (2). Exclusion of malignant tumors other than hepatocellular carcinoma, and severe cardiopulmonary diseases; (3). Incomplete clinical data. 2.Exclusion criteria for the control group: (1). Exclusion of viral hepatitis and cirrhosis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis and cirrhosis, drug-induced liver injury, Wilson’s disease, primary sclerosing cholangitis, hepatic sinusoidal obstruction syndrome, Budd-Chiari syndrome, or other liver diseases; (2). Exclusion of malignant tumors other than hepatocellular carcinoma, severe cardiopulmonary diseases; (3). Incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Esophagogastric variceal bleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hepatocellular carcinoma;Portal vein thrombosis, PVT;Prognosis; | — |
Countries
China
Contacts
Beijing Ditan Hospital, Capital Medical University